A meta-analysis of the efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis undergoing drainage

A meta-analysis of the efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis undergoing drainage

Bibliographic Details
Main Authors:	Ying-Jun Zheng, Shi-jie Zhuo, Bin Huang, Song Su
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Asian Journal of Surgery
Subjects:	cirrhosis Ascites Albumin Artificial colloid Meta-analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958421003171

Similar Items

Diagnostic utility of the serum–ascites albumin gradient in Mexican patients with ascites related to portal hypertension
by: Enrique Cervantes Pérez, et al.
Published: (2020-10-01)

The Role of Serum Ascites Albumin Gradient in the Differential Diagnosis of Ascites.
by: Hysni Dede, et al.
Published: (2022-01-01)

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real‐world cohort study
by: Nicholas Hannah, et al.
Published: (2023-08-01)

Comparison of Ascitic Fluid Cholesterol and Fibronectin with Conventional Ascitic Protein Values in Differentiating Malignant Ascites from Non malignant Ascites: A Cross-sectional Study
by: Thakura Soren, et al.
Published: (2023-11-01)

The Comparison of Total Protein of Ascites Fluid with Serum Ascites Albumin Gradient as Criterion in the Differential Diagnosis of Ascites
by: Mostafa Ansari, et al.
Published: (1999-09-01)

Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature
by: Zaccherini G, et al.
Published: (2020-10-01)

Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
by: Diego García-Compean, MD, et al.
Published: (2002-01-01)

Comparison of intermittent drainage of ascites and diuretic therapy for cirrhosis patients with tense ascites
by: Jun-feng Chen, et al.
Published: (2017-01-01)

Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01)

Advances in decompensated cirrhosis treatment by human serum albumin
by: ZHANG Chenxi, et al.
Published: (2023-01-01)

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Published: (2018-09-01)

The First Finding of Cirrhosis: Hepatic Hydrothorax Caused by Absence of Ascites
by: Yahya Atayan, et al.
Published: (2015-06-01)

A case of refractory ascites
by: Loris Varvello, et al.
Published: (2015-10-01)

Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
by: Amila Cizmic, et al.
Published: (2023-10-01)

Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt
by: Dongmei Zhao, et al.
Published: (2019-03-01)

Pathophysiology, diagnosis and treatment of ascites in cirrhosis
by: Vicente Arroyo, M.D.
Published: (2002-04-01)

Efficacy and Safety of Ascites Treatment in Liver Cirrhosis
by: G. A. Ignatenko, et al.
Published: (2022-07-01)

Effect of Ayurveda Management on Liver Cirrhosis with Ascites-A Retrospective Cohort Study
by: B.R. Tubaki, et al.
Published: (2022-04-01)

Identifying high and low serum-ascites albumin gradient in ascitic fluid by the point of care dipstick test
by: Leyli Asadabadi, et al.
Published: (2016-01-01)

Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
by: Cornelius Engelmann, et al.
Published: (2017-09-01)

Transjugular intrahepatic portosystemic shunt for chylous ascites in a patient with recurrent cirrhosis following liver transplantation
by: Jason T. Salsamendi, MD, et al.
Published: (2017-03-01)

Short‐term intraperitoneal catheters: An ambulatory care intervention for refractory ascites secondary to cirrhosis during COVID‐19
by: Natalie LY Ngu, et al.
Published: (2021-10-01)

RESPIRATORY AND SYMPTOMATIC IMPACT OF ASCITES RELIEF BY PARACENTESIS IN PATIENTS WITH HEPATIC CIRRHOSIS
by: Verônica Lourenço WITTMER, et al.
Published: (2020-02-01)

Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis
by: R.M. Catarino, et al.
Published: (2005-02-01)

Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study
by: Yen-Chun Chen, et al.
Published: (2022-01-01)

Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
by: Ana Garcia Garcia de Paredes, et al.
Published: (2021-12-01)

Ascites
by: Soung Won Jeong
Published: (2018-08-01)

SPONTANEOUS BACTERIAL PERITONITIS IN ASYMPTOMATIC CIRRHOTIC PATIENTS WITH ASCITES IN A TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL STUDY
by: Asif Aziz, et al.
Published: (2020-10-01)

Echocardiographic Findings in Cirrhotic Patients with and without Ascites Compared to Normal
by: M Kashifard, et al.
Published: (2010-10-01)

Partnering with charity‐care services to manage cirrhosis with ascites in an adult experiencing homelessness: A case report
by: Danzhu Zhao, et al.
Published: (2023-04-01)

The Role of Correcting Structural and Functional Albumin Properties in Ascites Control in Decompensated Cirrhotic Patients
by: A. A. Turkina, et al.
Published: (2023-09-01)

ASCITES IN THE CIRRHOTIC PATIENT: HOW TO APPROACH IT? (IN SPANISH)
by: Yepes-Barreto Ismael, et al.
Published: (2014-06-01)

Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives
by: Roberta Gagliardi, et al.
Published: (2023-11-01)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
by: Kurt Grüngreiff, et al.
Published: (2021-11-01)

Evaluating the effect of midodrine on renal resistance index in patients with liver cirrhosis and ascites
by: Hamdy M Moustafa, et al.
Published: (2016-01-01)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
by: Takuya Adachi, et al.
Published: (2021-05-01)

The Relationship Between the Mean Platelet Volume and the Development of Spontaneous Ascites Fluid Infection in Patients with Decompensated Cirrhosis
by: Ebru Sinem Bilgin, et al.
Published: (2020-10-01)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
by: Mingyu Li, et al.
Published: (2023-01-01)

Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis
by: Nakul Kadam, et al.
Published: (2016-04-01)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
by: M. Chris Runken, et al.
Published: (2019-07-01)